quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:33·700d
SECFiling
Alpine Immune Sciences Inc. logo

SEC Form EFFECT filed by Alpine Immune Sciences Inc.

ALPN· Alpine Immune Sciences Inc.
Health Care
Original source

Companies

  • ALPN
    Alpine Immune Sciences Inc.
    Health Care

Recent analyst ratings

  • Apr 9UpdateGuggenheim$55.00
  • Feb 15UpdateWolfe Research$44.00
  • Oct 18UpdateBerenberg$18.00
  • Oct 17UpdateBerenberg$18.00
  • Oct 5UpdateRBC Capital Mkts$19.00
  • Jun 26UpdateOppenheimer$14.00

Related

  • PR470d
    Frazier Life Sciences Appoints Biotech Innovators Mitchell H. Gold and Stanford L. Peng as Venture Partners
  • PR654d
    Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
  • SEC694d
    SEC Form 15-12G filed by Alpine Immune Sciences Inc.
  • SEC700d
    SEC Form EFFECT filed by Alpine Immune Sciences Inc.
  • 13D/G702d
    SEC Form SC 13D/A filed by Alpine Immune Sciences Inc. (Amendment)
  • 13D/G703d
    SEC Form SC 13D/A filed by Alpine Immune Sciences Inc. (Amendment)
  • INSIDER703d
    Peetz Christopher returned 1,900 shares to the company (SEC Form 4)
  • INSIDER703d
    SEC Form 4 filed by Hernday Natasha
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022